We are live on ! Find out more
IMCR icon

Immunocore
IMCR

49 hedge funds and large institutions have $642M invested in Immunocore in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 13 increasing their positions, 14 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

50% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 6

4% more funds holding

Funds holding: 47 → 49 (+2)

2.46% more ownership

Funds ownership: 38.78% → 41.23% (+2.5%)

4% more capital invested

Capital invested by funds: $617M → $642M (+$25M)

7% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 14

Holders
49
Holders Change
+2
Holders Change %
+4.26%
% of All Funds
0.75%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
9
Increased
13
Reduced
14
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$13.1M
2
First Manhattan
First Manhattan
New York
+$11.3M
3
RG
Rathbones Group
United Kingdom
+$6.88M
4
PC
Pier Capital
Connecticut
+$5.77M
5
APM
Avidity Partners Management
Texas
+$4.87M

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$12M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$4.95M
3
Millennium Management
Millennium Management
New York
-$3.48M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$2.09M
5
PA
Perceptive Advisors
New York
-$1.45M
Name Holding Trade Value Shares
Change 		Change in
Stake
AA
26
ALPS Advisors
Colorado
$1.74M -$108K -2,993 -6%
VIA
27
Vident Investment Advisory
Georgia
$1.05M +$1.11M +30,676 New
TD Asset Management
28
TD Asset Management
Ontario, Canada
$942K – – –
Marshall Wace
29
Marshall Wace
United Kingdom
$826K +$873K +24,120 New
Legal & General Group
30
Legal & General Group
United Kingdom
$765K -$105K -2,908 -12%
PVI
31
Pura Vida Investments
New York
$653K -$1.12M -30,929 -62%
EMG
32
ETF Managers Group
New Jersey
$460K -$102K -2,807 -17%
Point72 Asset Management
33
Point72 Asset Management
Connecticut
$425K -$4.95M -136,600 -92%
Citadel Advisors
34
Citadel Advisors
Florida
$415K -$377K -10,405 -46%
UBS Group
35
UBS Group
Switzerland
$323K -$165K -4,556 -33%
Victory Capital Management
36
Victory Capital Management
Texas
$280K -$48.6K -1,342 -14%
State Street
37
State Street
Massachusetts
$216K +$4.2K +116 +2%
Geode Capital Management
38
Geode Capital Management
Massachusetts
$205K – – –
VEA
39
Virtus ETF Advisers
New York
$189K +$5.94K +164 +3%
Zurich Cantonal Bank
40
Zurich Cantonal Bank
Switzerland
$132K – – –
Bank of America
41
Bank of America
North Carolina
$121K +$47.2K +1,305 +58%
Morgan Stanley
42
Morgan Stanley
New York
$48K -$33.2K -916 -39%
Rockefeller Capital Management
43
Rockefeller Capital Management
New York
$34K +$36.2K +1,000 New
MIM
44
Meridiem Investment Management
United Kingdom
$20K +$20.8K +575 New
SOW
45
State of Wyoming
Wyoming
$5K -$253 -7 -5%
Osaic Holdings
46
Osaic Holdings
Arizona
$5K +$760 +21 +17%
TRCT
47
Tower Research Capital (TRC)
New York
$1K +$688 +19 New
Millennium Management
48
Millennium Management
New York
– -$3.48M -93,812 Closed
BFM
49
Boothbay Fund Management
New York
– -$253K -6,826 Closed
GWM
50
Geneos Wealth Management
Colorado
– -$163K -4,250 Closed
1
2
3

IMCR Hedge Fund Activity: Q4 2021 in Review

49 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Immunocore (IMCR) for Q4 2021, worth a combined $642M — up 4.1% from $617M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new IMCR positions and 6 closed out — a net gain of 3 holders — while 13 added to existing stakes and 14 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $13.1M. The largest seller was BlackRock, cutting an estimated $12M.

  • 49 institutional investors held Immunocore (IMCR) as of Q4 2021, up from 47 in Q3 2021.
  • Funds reported $642M of Immunocore stock for Q4 2021, up 4.1% quarter-over-quarter.
  • 9 funds opened new Immunocore positions in Q4 2021 and 6 closed out, a net change of +3 holders.
  • The largest Immunocore buyer in Q4 2021 was Wellington Management Group, an estimated $13.1M added.
  • The largest Immunocore seller in Q4 2021 was BlackRock, an estimated $12M sold.

Based on aggregated 13F filings for Q4 2021.